Literature DB >> 31911016

A Review of Modern Radiation Therapy Dose Escalation in Locally Advanced Head and Neck Cancer.

D Atwell1, J Elks2, K Cahill3, N Hearn4, D Vignarajah5, J Lagopoulos2, M Min4.   

Abstract

The management of head and neck cancer is complex and often involves multimodality treatment. Certain groups of patients, such as those with inoperable or advanced disease, are at higher risk of treatment failure and may therefore benefit from radiation therapy dose escalation. This can be difficult to achieve without increasing toxicity. However, the combination of modern treatment techniques and increased research into the use of functional imaging modalities that assist with target delineation allows researchers to push this boundary further. This review aims to summarise modern dose escalation trials to identify the impact on disease outcomes and explore the growing role of functional imaging modalities. Studies experimenting with dose escalation above standard fractionated regimens as outlined in National Comprehensive Cancer Network guidelines using photon therapy were chosen for review. Seventeen papers were considered suitable for inclusion in the review. Eight studies investigated nasopharyngeal cancer, with the remainder treating a range of subsites. Six studies utilised functional imaging modalities for target delineation. Doses as high as 85.9 Gy in 2.6 Gy fractions (EQD2 90.2 Gy10) were reportedly delivered with the aid of functional imaging modalities. Dose escalation in nasopharyngeal cancer resulted in 3-year locoregional control rates of 86.6-100% and overall survival of 82-95.2%. For other mucosal primary tumour sites, 3-year locoregional control reached 68.2-85.9% and 48.4-54% for overall survival. There were no clear trends in acute or late toxicity across studies, regardless of dose or addition of chemotherapy. However, small cohort sizes and short follow-up times may have resulted in under-reporting. This review highlights the future possibilities of radiation therapy dose escalation in head and neck cancer and the potential for improved target delineation with careful patient selection and the assistance of functional imaging modalities.
Copyright © 2019 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dose escalation; functional imaging; head and neck neoplasm; radiation oncology

Year:  2020        PMID: 31911016     DOI: 10.1016/j.clon.2019.12.004

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  8 in total

Review 1.  Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology.

Authors:  Travis C Salzillo; Nicolette Taku; Kareem A Wahid; Brigid A McDonald; Jarey Wang; Lisanne V van Dijk; Jillian M Rigert; Abdallah S R Mohamed; Jihong Wang; Stephen Y Lai; Clifton D Fuller
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

2.  Initial Experience of Intentional Internal High-Dose Policy Volumetric Modulated Arc Therapy of Neck Lymph Node Metastases ≥ 2 cm in Patients With Head and Neck Squamous Cell Carcinoma.

Authors:  Tairo Kashihara; Satoshi Nakamura; Naoya Murakami; Kimiteru Ito; Yoshifumi Matsumoto; Kenya Kobayashi; Go Omura; Taisuke Mori; Yoshitaka Honma; Yuko Kubo; Hiroyuki Okamoto; Kana Takahashi; Koji Inaba; Kae Okuma; Hiroshi Igaki; Yuko Nakayama; Ken Kato; Fumihiko Matsumoto; Seiichi Yoshimoto; Jun Itami
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

Review 3.  Oncoimmunology Meets Organs-on-Chip.

Authors:  Fabrizio Mattei; Sara Andreone; Arianna Mencattini; Adele De Ninno; Luca Businaro; Eugenio Martinelli; Giovanna Schiavoni
Journal:  Front Mol Biosci       Date:  2021-03-26

4.  Recurrence Patterns After IMRT/VMAT in Head and Neck Cancer.

Authors:  Heleen Bollen; Julie van der Veen; Annouschka Laenen; Sandra Nuyts
Journal:  Front Oncol       Date:  2021-09-16       Impact factor: 6.244

5.  Adaptive dose escalated radiotherapy in oropharyngeal cancers: a treatment planning feasibility study.

Authors:  Laura Grocutt; Claire Paterson; Ronan M Valentine
Journal:  Radiat Oncol       Date:  2022-02-05       Impact factor: 3.481

6.  Boron Neutron Capture Therapy (BNCT) Mediated by Maleimide-Functionalized Closo-Dodecaborate Albumin Conjugates (MID:BSA) for Oral Cancer: Biodistribution Studies and In Vivo BNCT in the Hamster Cheek Pouch Oral Cancer Model.

Authors:  Andrea Monti Hughes; Jessica A Goldfinger; Mónica A Palmieri; Paula Ramos; Iara S Santa Cruz; Luciana De Leo; Marcela A Garabalino; Silvia I Thorp; Paula Curotto; Emiliano C C Pozzi; Kazuki Kawai; Shinichi Sato; María E Itoiz; Verónica A Trivillin; Juan S Guidobono; Hiroyuki Nakamura; Amanda E Schwint
Journal:  Life (Basel)       Date:  2022-07-20

Review 7.  FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer.

Authors:  Martin Dolezel; Marek Slavik; Tomas Blazek; Tomas Kazda; Pavel Koranda; Lucia Veverkova; Petr Burkon; Jakub Cvek
Journal:  J Pers Med       Date:  2022-07-29

8.  Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost.

Authors:  Tomáš Blažek; Zuzana Zděblová Čermáková; Lukáš Knybel; Pavel Hurník; Jan Štembírek; Kamila Resová; Tereza Paračková; Martin Formánek; Jakub Cvek; Renata Soumarová
Journal:  Radiat Oncol       Date:  2021-06-29       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.